New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 30, 2013
11:42 EDTVNDA, SUPN, IRMOptions with increasing implied volatility: VNDA SUPN JCP IRM
News For VNDA;SUPN;IRM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 23, 2014
08:36 EDTIRMProgress Software names Melissa Puls as Chief Marketing Officer
Progress (PRGS) announced the appointment of Melissa Puls to chief marketing officer, effective October 20, 2014. As CMO, Puls will oversee all aspects of the companyís marketing operations and communications strategy. Puls will report into Progress president and CEO, Phil Pead. Puls most recently served as the vice president of Iron Mountainís (IRM) Global Demand Center, where she led demand generation, content marketing, web marketing, marketing operations, and creative services.
October 22, 2014
08:33 EDTIRMIron Mountain signs multi-year data center colocation agreement with Englewood
Iron Mountain announced it has signed a multi-year data center colocation agreement with Englewood Hospital and Medical Center, an acute care teaching hospital affiliated with the Mount Sinai School of Medicine in Englewood, New Jersey. Englewood Hospital will lease data center space within Iron Mountainís underground data center located near Pittsburgh, Pennsylvania.
October 14, 2014
17:00 EDTIRMIron Mountain closes on purchase of Keepers Brazil
Subscribe for More Information
09:08 EDTSUPNSupernus announces Paragraph IV ANDA filing for Trokendi XR
Supernus Pharmaceuticals announced that on October 13, the company received a Paragraph IV Notice Letter from Zydus Pharmaceuticals advising Supernus of the filing by Zydus of an Abbreviated New Drug Application seeking approval for topiramate extended-release capsules. Supernus is currently reviewing the details of this Notice Letter and intends to vigorously enforce its intellectual property rights relating to Trokendi XR. The product is currently protected by three issued patents that are listed in the FDA's Orange Book and expire no earlier than 2027.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use